Fig. 2. Treatment algorithm based on the disease severity (adapted from the article of Lee et al. Intest Res 2013;11:155-60 [
39]). DAIBD: Disease Activity Index of intestinal Behçet’s disease, 5-ASA: 5-Aminosalicylic acids, AZA: azathioprine, 6-MP: 6-mercaptopurine, MTX: methotrexate, IMM: immunomodulator.
